| Acute Leukemia |
0 |
0.99 |
| Acute Lymphoblastic Leukemia |
0 |
1 |
| Leukemia |
0 |
0.65 |
| Biologic Therapy |
0 |
0.55 |
| Chemotherapy |
0 |
0.5 |
| Tyrosine Kinase Inhibitor |
0 |
0.98 |
| HIV Infection |
0 |
0.27 |
| Stem Cell Research and Therapy |
0 |
0.27 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.22 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.21 |
| Prognosis |
0 |
0.21 |
| Tyrosine Kinase |
0 |
0.21 |
| Cell Transplantation |
0 |
0.15 |
| Remission |
0 |
0.14 |
| Transplantation |
0 |
0.14 |
| Cancer |
0 |
0.07 |
| Lymphoma |
0 |
0.07 |
| Monoclonal Antibody |
0 |
0.07 |
| Multiple Myeloma |
0 |
0.07 |
| Spine |
0 |
0.07 |
| Texas |
0 |
0.07 |